Group 1 - The core viewpoint of the articles highlights the fundraising activities of companies listed on the STAR Market, with a total of 7 companies raising 7.901 billion yuan this year, averaging 1.129 billion yuan per company [1][2] - The company with the highest fundraising amount is Yitang Co., Ltd., which raised 2.497 billion yuan primarily for technology development and reserve funds [1] - Other notable companies include Yingshi Innovation, which raised 1.938 billion yuan for its R&D center and production base, and Xingfu Electronics, which raised 1.168 billion yuan [1] Group 2 - The average initial offering price for STAR Market stocks this year is 21.73 yuan, with Yingshi Innovation having the highest price at 47.27 yuan [1] - The issuance price of Yitang Co., Ltd. is the lowest at 8.45 yuan, while other companies like Sikan Technology and Hanbang Technology have initial prices of 33.46 yuan and 22.77 yuan respectively [1] - The issuance price-earnings ratio for the listed companies ranges from 6.14 to 51.55, with an average of 30.03 and a median of 26.35 [2] Group 3 - Geographically, the majority of the issued STAR Market companies are concentrated in Beijing, Jiangsu, and Hubei, with fundraising amounts led by Beijing at 3.359 billion yuan [2] - The companies with issuance price-earnings ratios above the industry average include Yitang Co., Ltd. and two others, while five companies fall below the industry average [2] - The detailed fundraising data for the listed companies includes their codes, names, issuance dates, prices, price-earnings ratios, and total funds raised [2]

Group 1 - The stock of Shengke Nano increased by 19.99%, reaching the daily price limit of 15% for stocks with price fluctuation limits [1] - The trading volume showed a significant net buying amount of 4256.28 million, with total buying of 7515.07 million and selling of 3258.80 million [1] - Major buying institutions included Guotai Junan Securities and Huatai Securities, with the top three buying amounts being 2612.35 million, 1685.23 million, and 1266.73 million respectively [2] Group 2 - The largest selling amounts came from Guotai Junan Securities, with a sell amount of 800.00 million, followed by Guoxin Securities and Goldman Sachs (China) with sell amounts of 732.89 million and 585.88 million respectively [2] - The data indicates a strong interest from institutional investors in Shengke Nano, as evidenced by the high net buying figures [1][2]

Group 1 - The investment rating for the company is not explicitly stated in the provided documents [1] - The core viewpoint of the report highlights that the company is a leading semiconductor third-party testing enterprise in China, often referred to as the "chip general hospital" [1][9] - The company has achieved a compound annual growth rate (CAGR) of 35% in revenue and 43% in net profit from 2021 to 2024, with a market share of 7.86% in failure analysis and material analysis in 2023 [1][13][35] Group 2 - The semiconductor third-party testing industry is experiencing growth driven by rapid technological iterations, domestic industrialization, and increased process tolerance requirements [2][33] - The market for third-party laboratory testing is expected to reach 180-200 billion yuan in China by 2027, with a global market size projected to reach 6.677 billion USD [35][36] - The industry is characterized by a fragmented competitive landscape, but leading companies are expected to benefit significantly from the growth in demand and the deepening of the Labless model [2][40] Group 3 - The company has a strong technical capability, covering advanced process testing down to 3nm, and serves over 2,000 global clients, including major semiconductor firms like Qualcomm and Broadcom [3][9] - The company focuses on high-margin services such as failure analysis (FA) and material analysis (MA), which accounted for 97.09% of its revenue in the first half of 2024 [10][44] - The company maintains a high gross margin of 46.86% in 2024, supported by a robust revenue structure and effective cost management [13][24]

证券代码：688757 证券简称：胜科纳米 公告编号：2025-021 胜科纳米（苏州）股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 1. 发放年度：2024年年度 2. 分派对象： 三、 相关日期 | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/6/27 | 2025/6/30 | 2025/6/30 | 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 6 月 16 日的2024年年度股东会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本403,311,486股为基数，每股派发现 金红利0.149元（含税），共计派发现金红利60,093,411.41元（含税）。 是否涉及差异化分红送转：否 每股分 ...

上海市锦天城律师事务所 关于胜科纳米（苏州）股份有限公司 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于胜科纳米（苏州）股份有限公司 法律意见书 致：胜科纳米（苏州）股份有限公司 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东会所涉及的相关事项 进行了必要的核查和验证，核查了本所认为出具该法律意见书所需的相关文件、 资料，并参加了公司本次股东会的全过程。本所保证本法律意见书所认定的事实 真实、准确、完整，所发表的结论性意见合法、准确，不存在虚假记载、误导性 陈述或者重大遗漏，并愿意承担相应法律责任。 本所同意将本法律意见书与本次股东会的决议一并进行公告，并依法对发表 的法律意见承担相应法律责任。 鉴此，本所律师根据上述法律、法规、规章及规范性文件的要求，按照律师 行业公认的业务标准 ...

股东类型 比例 比例 比例 票数 票数 票数 | 普通股 | | 304,028,929 | （%） 99.9850 | 40,678 | （%） 0.0133 | 4,929 | 0.0017 | （%） | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 审议结果：通过 | | | | | | | | | | 表决情况： | 同意 | | 反对 | | | 弃权 | | | | 股东类型 | | 比例 | | 比例 | | | 比例 | | | | 票数 | | 票数 | | 票数 | | | | | | | （%） | | （%） | | | （%） | | 普通股 | | 304,028,929 | 99.9850 | 40,678 | 0.0133 | 4,929 | 0.0017 | | | | 审议结果：通过 | | | | | | | | | | 表决情况： | | | | | | | | | | | 同意 | | 反对 | | | 弃权 | | | | 股东类型 | | 比例 | | 比例 | | | 比例 | | | ...

本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 证券代码：688757 证券简称：胜科纳米 公告编号：2025-020 胜科纳米（苏州）股份有限公司 2024年年度股东会决议公告 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 6 月 16 日 二、 议案审议情况 （二） 股东会召开的地点：江苏省苏州市工业园区朝前路 9 号公司会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 88 | | --- | --- | | 普通股股东人数 | 88 | | 2、出席会议的股东所持有的表决权数量 | 304,074,536 | | 普通股股东所持有表决权数量 | 304,074,536 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 75.3944 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 75.3944 | ...

上海市锦天城律师事务所 关于胜科纳米（苏州）股份有限公司 2024 年年度股东会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于胜科纳米（苏州）股份有限公司 2024 年年度股东会的 法律意见书 致：胜科纳米（苏州）股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受胜科纳米（苏州）股份有 限公司（以下简称"公司"）委托，就公司召开 2024 年年度股东会（以下简称"本 次股东会"）的有关事宜，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《上市公司股东会规则》等法律、法规、规章和其他规范性文件以及《胜科纳米 （苏州）股份有限公司章程》（以下简称"《公司章程》"）的有关规定，出具本 法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东会所涉及的相关事项 ...

胜科纳米（苏州）股份有限公司 2024 年年度股东会 证券代码：688757 证券简称：胜科纳米 胜科纳米（苏州）股份有限公司 2024年年度股东会 会议资料 2025年6月16日 | 2024 | 年年度股东会会议须知 | 1 | | --- | --- | --- | | 2024 | 年年度股东会会议议程 | 3 | | 2024 | 年年度股东会会议议案 | 6 | 胜科纳米（苏州）股份有限公司 2024 年年度股东会 胜科纳米（苏州）股份有限公司 2024 年年度股东会会议须知 为维护广大投资者的合法权益，保障股东在本次股东会期间依法行使权利， 根据《中华人民共和国公司法》、中国证券监督管理委员会《上市公司股东会规 则》等法律法规和胜科纳米（苏州）股份有限公司（以下简称"公司"）《股东 会议事规则》等有关规定，特制定本会议须知： 一、公司负责本次股东会的议程安排和会务工作，为确认出席会议的股东或 其代理人或其他出席者的出席资格，会议工作人员将对出席会议者的身份进行必 要的核对工作，请被核对者给予配合。 二、出席会议的股东及股东代理人须在会议召开前半小时到会议现场办理签 到手续，并按规定出示身份证明文 ...

Core Viewpoint - The 2024 Annual General Meeting of Shengke Nano (Suzhou) Co., Ltd. is set to discuss various proposals, including financial reports, budget plans, and governance changes, reflecting the company's commitment to transparency and shareholder engagement [1][6][20]. Meeting Procedures - The company has established guidelines for the meeting to ensure the rights of shareholders are protected, including identity verification for attendees and a structured agenda for discussions and voting [1][2][4]. - Shareholders must register at least 30 minutes before the meeting and present necessary documentation to participate in the voting process [2][3]. Voting and Proposals - The meeting will utilize a combination of on-site and online voting methods, with specific timeframes for each [4][5]. - Key proposals include the 2024 Board of Directors' work report, financial statements, and the 2025 budget plan, all of which have been approved by the board and are now presented for shareholder approval [6][9][10]. Financial Performance - For the fiscal year 2024, the company reported a net profit of approximately 81.18 million yuan, a decrease of 17.61% compared to the previous year [24][32]. - The total revenue for 2024 was approximately 415.27 million yuan, reflecting a growth of 5.40% year-on-year, while the operating profit decreased by 19.34% to about 89.83 million yuan [33]. Governance Changes - The company plans to abolish the supervisory board, transferring its responsibilities to the audit committee of the board of directors, which aims to streamline governance and enhance operational efficiency [20][21][23]. - Proposed amendments to the company's articles of association will align with new regulatory requirements and improve governance practices [21][23]. Financial Proposals - The company proposes a cash dividend of 1.49 yuan per share for the 2024 fiscal year, which represents 74.02% of the net profit attributable to shareholders [18][24]. - A proposal for a credit limit of up to 2 billion yuan for the company and its subsidiaries is also on the agenda, aimed at supporting operational and developmental funding needs [14][16].